Close



Mar 14, 2024 06:32AM
Feb 28, 2024 04:03PM
Jan 8, 2024 08:35AM
Jan 8, 2024 08:30AM
Nov 2, 2023 04:05PM
Oct 17, 2023 04:30PM
Oct 17, 2023 04:30PM Mirum Pharmaceuticals Announces New PDUFA Date for LIVMARLI for the Treatment of Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis
Aug 3, 2023 04:05PM
May 4, 2023 04:02PM
Sep 30, 2021 12:14PM
Sep 22, 2021 09:49AM
Sep 21, 2021 08:06AM
Sep 21, 2021 08:00AM
Sep 13, 2021 06:47AM Mirum Pharma (MIRM) Submits European MAA for Maralixibat in Alagille Syndrome Supported by New Positive Results from Natural History Study Comparison
Sep 13, 2021 06:45AM
Sep 10, 2021 05:30PM
Sep 2, 2021 05:30PM
Aug 19, 2021 05:32PM
Aug 19, 2021 05:30PM
Aug 10, 2021 07:00PM
Aug 5, 2021 04:02PM Mirum Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
Jul 29, 2021 04:00PM
Jul 26, 2021 08:00PM
Jul 12, 2021 06:00PM
Jun 24, 2021 04:05PM
Jun 23, 2021 09:07AM
Jun 23, 2021 09:00AM
Jun 16, 2021 09:00AM Mirum Pharmaceuticals to Showcase Analyses From Its Rare Liver Disease Programs at The International Liver Congress 2021
Jun 10, 2021 05:30PM
Jun 7, 2021 09:02AM
Jun 7, 2021 09:00AM
Jun 3, 2021 10:10AM
May 26, 2021 09:00AM
May 10, 2021 09:00PM
May 6, 2021 04:05PM Mirum Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
Apr 29, 2021 04:05PM
Apr 29, 2021 08:17AM
Apr 29, 2021 08:00AM
Apr 29, 2021 08:00AM
Apr 26, 2021 09:03AM
Apr 26, 2021 09:00AM
Apr 12, 2021 05:30PM Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 12, 2021 08:01AM
Apr 12, 2021 08:00AM
Mar 29, 2021 09:01AM
Mar 29, 2021 09:00AM

12,447 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All